TY - JOUR
T1 - A hormone response element upstream from the human alcohol dehydrogenase gene ADH2 consists of three tandem glucocorticoid receptor binding sites
AU - Winter, Laurie A.
AU - Stewart, Mark J.
AU - Shean, Mary Luo
AU - Dong, Yu
AU - Poellinger, Lorenz
AU - Okret, Sam
AU - Gustafsson, Jan Äke
AU - Duester, Gregg
N1 - Funding Information:
We thank R. Evans, H. Fan, I,. Marsh, R. Weinmann and K. Yamamotof or plasmidsp MTV-CAT, pFACAT, plC, pDPSCAT, and pSVGRI, respectivelyB; . Knowles for supplyingt he HepG2 cell line; and S. McBride for excellentte chnicaal ssistanceW. e gratefullya cknowledgJe. Carlstedt-Dukea nd P.-E. Stromstedtfo r purified gluco-corticoidr eceptorT. his researchw as supportedb y Grant AA07261 from the National Institute on Alcohol Abuse and Alcoholism( G.D.), a BiomedicalR esearchS upport Grant from the National Instituteso f Health (G.D.), a postdoctoralf ellowshipf t~3mt he Karolinska lnstitutet (S.O.), and Grant 13X-2819f rom the SwedishM edical Research Council (J.-,~.G.). G.D. is a recipient of a ResearchS cicntistD evelopmenAtw ard (K02 AA00119) from the National Instituteo n Alcohol Abuse and Alco-holism.
PY - 1990/7/16
Y1 - 1990/7/16
N2 - The 5′-flanking region of the human gene encoding β-alcohol dehydrogenase (ADH2) was shown by DNase I footprinting to contain three tandem binding sites for purified glucocorticoid receptor. The three binding sites lie very close together between nucleotide (nt) positions -245 and -171 with respect to the transcription start point. DNase I footprinting using a rat liver nuclear extract indicated a lack of protection of the glucocorticoid receptor binding sites, but protection of a sequence between nt -209 and -191 which partially overlaps the glucocorticoid receptor binding sites I and II. This site has homology with the known binding site for hepatocyte nuclear factor 1 (HNF1). ADH2 promoter DNA fragments containing various lengths of 5′-flanking sequences were fused upstream from the gene encoding chloramphenicol acetyltransferase (cat) and transfected into the HepG2 human hepatoma cell line. The resulting cat expression was subject to induction by dexamethasone in constructions containing ADH2 DNA between nt -272 and -171. This indicates that the glucocorticoid receptor binding sites identified by footprint analysis function as a glucocorticoid response element (GRE) in a liver cell line. Heterologous ADH-cat fusions, in which the ADH2-GRE was fused to the adenovirus major late promoter, exhibited glucocorticoid induction of cat expression in CV-1B cells when cotransfected with a glucocorticoid receptor expression vector. Glucocorticoid regulation in CV-1B was observed when either all three glucocorticoid receptor binding sites (sites 0, I, II) or the two distal sites (sites 0, I) were present. Overall, these results indicate that the ADH2 gene possesses a functional GRE which can potentially regulate expression transcriptionally. Since previous findings have indicated that glucocorticoids play a permissive role in the induction of mammalian ADH during ethanol ingestion, the finding of a GRE in the human ADH2 gene suggests that the mechanism of this induction involves transcriptional control via the glucocorticoid receptor.
AB - The 5′-flanking region of the human gene encoding β-alcohol dehydrogenase (ADH2) was shown by DNase I footprinting to contain three tandem binding sites for purified glucocorticoid receptor. The three binding sites lie very close together between nucleotide (nt) positions -245 and -171 with respect to the transcription start point. DNase I footprinting using a rat liver nuclear extract indicated a lack of protection of the glucocorticoid receptor binding sites, but protection of a sequence between nt -209 and -191 which partially overlaps the glucocorticoid receptor binding sites I and II. This site has homology with the known binding site for hepatocyte nuclear factor 1 (HNF1). ADH2 promoter DNA fragments containing various lengths of 5′-flanking sequences were fused upstream from the gene encoding chloramphenicol acetyltransferase (cat) and transfected into the HepG2 human hepatoma cell line. The resulting cat expression was subject to induction by dexamethasone in constructions containing ADH2 DNA between nt -272 and -171. This indicates that the glucocorticoid receptor binding sites identified by footprint analysis function as a glucocorticoid response element (GRE) in a liver cell line. Heterologous ADH-cat fusions, in which the ADH2-GRE was fused to the adenovirus major late promoter, exhibited glucocorticoid induction of cat expression in CV-1B cells when cotransfected with a glucocorticoid receptor expression vector. Glucocorticoid regulation in CV-1B was observed when either all three glucocorticoid receptor binding sites (sites 0, I, II) or the two distal sites (sites 0, I) were present. Overall, these results indicate that the ADH2 gene possesses a functional GRE which can potentially regulate expression transcriptionally. Since previous findings have indicated that glucocorticoids play a permissive role in the induction of mammalian ADH during ethanol ingestion, the finding of a GRE in the human ADH2 gene suggests that the mechanism of this induction involves transcriptional control via the glucocorticoid receptor.
KW - DNase I footprinting
KW - Glucocorticoid response element
KW - recombinant DNA
KW - transcription
KW - transient transfection
UR - http://www.scopus.com/inward/record.url?scp=0025102111&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025102111&partnerID=8YFLogxK
U2 - 10.1016/0378-1119(90)90093-7
DO - 10.1016/0378-1119(90)90093-7
M3 - Article
C2 - 2210383
AN - SCOPUS:0025102111
SN - 0378-1119
VL - 91
SP - 233
EP - 240
JO - Gene
JF - Gene
IS - 2
ER -